» Articles » PMID: 15921811

Economic Burden of Post-acute Myocardial Infarction Heart Failure in the United Kingdom

Overview
Publisher Wiley
Date 2005 Jun 1
PMID 15921811
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Congestive heart failure (CHF) is a major cause of morbidity and mortality. This study was carried out to quantify the burden of CHF, subsequent to acute myocardial infarction (AMI), from the perspective of the UK National Health Service (NHS). A systematic literature review of publications since 1990 was carried out on the economic burden of heart failure. The economic burden of post-AMI heart failure in the UK for the year 2000 was estimated for two scenarios: (1) Base-case estimate (post-AMI heart failure accounts for 20% of heart failure cases): Direct healthcare costs of pound 125-181 million (approx. 0.4% of total NHS spend) and nursing home costs of pound 27 million; (2) Upper estimate (post-AMI heart failure accounts for 50% of the total): Direct healthcare costs of pound 313-453 million (approx 1.0% of total NHS spend) and nursing home costs of pound 68 million. In conclusion, post-AMI heart failure imposes a significant direct economic burden on the UK.

Citing Articles

Establishment and validation of a prediction nomogram for heart failure risk in patients with acute myocardial infarction during hospitalization.

Chen S, Pan X, Mo J, Wang B BMC Cardiovasc Disord. 2023; 23(1):619.

PMID: 38110880 PMC: 10726532. DOI: 10.1186/s12872-023-03665-2.


Impaired Diastolic Function Predicts Improved Ischemic Myocardial Flow by Mechanical Left Ventricular Unloading in a Swine Model of Ischemic Heart Failure.

Sakata T, Watanabe S, Mazurek R, Mavropoulos S, Romeo F, Yamada K Front Cardiovasc Med. 2022; 8:795322.

PMID: 35097014 PMC: 8790047. DOI: 10.3389/fcvm.2021.795322.


Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection.

Singhanat K, Apaijai N, Jaiwongkam T, Kerdphoo S, Chattipakorn S, Chattipakorn N J Adv Res. 2021; 29:33-44.

PMID: 33842003 PMC: 8020169. DOI: 10.1016/j.jare.2020.09.007.


Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs - an analysis of real-world data.

Kirsch F, Becker C, Kurz C, Schwettmann L, Schramm A BMC Health Serv Res. 2020; 20(1):1145.

PMID: 33342431 PMC: 7751107. DOI: 10.1186/s12913-020-05946-4.


Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.

Kirsch F, Becker C, Schramm A, Maier W, Leidl R Eur J Health Econ. 2020; 21(4):607-619.

PMID: 32006188 PMC: 7214389. DOI: 10.1007/s10198-020-01158-z.